Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-21-219850
Filing Date
2021-07-21
Accepted
2021-07-20 20:01:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-1/A d120909ds1a.htm S-1/A 78029
2 EX-99.1 d120909dex991.htm EX-99.1 2818
  Complete submission text file 0001193125-21-219850.txt   81954
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-257444 | Film No.: 211102375
SIC: 2836 Biological Products, (No Diagnostic Substances)